Fundraising Fox
enGene
Founded 1999 · 136 employees on LinkedIn · 2 known investors
Find your way into enGene
Sign up to find every way you can get introduced to enGene
- Your email: who you already know at enGene, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the enGene team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
Investors · 2
Related companies · 3
AdageneAdagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.
OrigeneOriGene develops and manufactures research and diagnostic products, including large-scale GMP antibody production, with R&D and research manufacturing operations. It serves the life sciences and biotech research market from facilities in the US and Germany.
Enzene Biosciences LtdEnzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.
Companies working in the same space as enGene.
In the news
Frequently asked questions
- What does enGene do?
- enGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
- Who are enGene's investors?
- enGene's investors include CTI Life Sciences Fund L.P., Lumira Ventures.